Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II

Fundam Clin Pharmacol. 2001 Aug;15(4):227-31. doi: 10.1046/j.1472-8206.2001.00032.x.

Abstract

Human urotensin-II (hU-II) is a cyclic peptide recently cloned in humans and present in human cardiac tissue and human arteries. The effects of hU-II were studied on human coronary bypass grafts in vitro. In three out of eight human mammary arteries, and two out of three human radial arteries, hU-II caused contraction; human saphenous veins did not respond to hU-II. When it exists, the contraction slowly develops and has a low-to-moderate intensity. All radial arteries obtained from young healthy non-human primates contracted strongly to hU-II.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Animals
  • Arteries / drug effects*
  • Arteries / physiology
  • Coronary Artery Bypass*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Macaca fascicularis
  • Male
  • Mammary Arteries / drug effects
  • Mammary Arteries / physiology
  • Radial Artery / drug effects
  • Radial Artery / physiology
  • Rats
  • Saphenous Vein / drug effects
  • Saphenous Vein / physiology
  • Urotensins / pharmacology*
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology

Substances

  • Urotensins
  • urotensin II